Non-clinical evaluation strategy for proteolysis-targeting chimera (PROTAC) pharmaceuticals

HAN Jun-yuan, LI Ya-juan, WANG Hai-xue, WANG Quan-jun

PDF(460 KB)
Chinese Journal of Pharmacology and Toxicology
PDF(460 KB)
Chinese Journal of Pharmacology and Toxicology ›› 2021, Vol. 35 ›› Issue (1) : 65-71. DOI: 10.3867/j.issn.1000-3002.2021.01.009
REVIEWS

Non-clinical evaluation strategy for proteolysis-targeting chimera (PROTAC) pharmaceuticals

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 35(1): 65-71 https://doi.org/10.3867/j.issn.1000-3002.2021.01.009

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(460 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉